+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

CSF monoamine metabolites in mania



CSF monoamine metabolites in mania



American Journal of Psychiatry 140(4): 396-400



As part of the National Institute of Mental Health Clinical Research Branch Collaborative Program on the Psychobiology of Depression, the authors compared concentrations of CSF monoamine metabolites (the norepinephrine metabolite 3-methoxy-4-hydroxyphenylglycol [MHPG], the dopamine metabolite homovanillic acid [HVA], and the serotonin metabolite 5-hydroxyindoleacetic acid [5-HIAA]) from 14 hospitalized manic patients with concentrations from 62 healthy comparison subjects. The manic patients had significantly higher levels of MHPG. Levels of 5-HIAA and HVA did not differ between the manic patients and the comparison male subjects, but they were elevated in the female manic patients. MHPG was the only metabolite that correlated significantly with mania symptom ratings. These data are consistent with findings that have shown abnormal, perhaps excessive, central noradrenergic activity in patients with mania, but not with those suggesting deficits in serotoninergic function.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 042429326

Download citation: RISBibTeXText

PMID: 6188381

DOI: 10.1176/ajp.140.4.396


Related references

Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania. Journal of Neurochemistry 13(12): 1545-1548, 1966

Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome. Archives of General Psychiatry 44(4): 345-354, 1987

Lithium distribution in mania plasma and red blood cell lithium clinical state and monoamine metabolites during lithium treatment. Psychiatry Research 20(1): 1-12, 1987

Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's disease. Journal of Neural Transmission Parkinson's Disease and Dementia Section 5(3): 193-202, 1993

Effect of aging on lazabemide binding, monoamine oxidase activity and monoamine metabolites in human frontal cortex. Journal Of Neural Transmission General Section. 101(1-3): 83-94, 1995

Effect of ischemia on monoamine metabolism. Brain monoamine metabolites in cerebrospinal fluid of patients with recent cerebral infarction. Neuropatologia Polska 20(1-2): 97-105, 1982

Comparative study of phenothiazine derivatives on monoamine metabolism--direct correlation between the concentrations of drugs and monoamine metabolites in the brain. Journal of Pharmacology and Experimental Therapeutics 240(3): 959-965, 1987

Phenothiazine derivatives and intracerebral monoamine metabolism: Application of direct correlation analysis between the levels of drugs and monoamine metabolites in rat brain. Nichidai Igaku Zasshi 53(9): 701-709, 1994

Changes in monoamine and monoamine metabolites in the nucleus accumbens and locomotor activity caused by p-chloroamphetamine: studies with intracerebral dialysis in freely moving rats. Seishin Shinkeigaku Zasshi 95(7): 507-522, 1993

Pharmacokinetics of oral moclobemide in healthy human subjects and effects on monoamine oxidase activity in platelets and excretion of urine monoamine metabolites. European Journal of Clinical Pharmacology 28(1): 89-96, 1985

Mania associated with high percentage of inhibition of monoamine oxidase. American Journal of Psychiatry 146(1): 121-121, 1989

Mania following addition of hydroxytryptophan to monoamine oxidase inhibitor. General Hospital Psychiatry 34(1): 102.E13-4, 2012

Determination of monoamine and monoamine metabolites in the human brain: post mortem studies in a group of suicides and in a control group. Acta Psychiatrica Scandinavica 53(1): 7-20, 1976